Kim Witherspoon

Senior Program Specialist, Biologist

Ms. Kim Witherspoon has been a part of the Cancer Therapy Evaluation Program (CTEP) since September 2000. She became part CTEP’s Investigational Drug Branch (IDB) in February 2018. In IDB, Kim ensures compliance with NIH and NCI grant policy. She is Senior Program Specialist for the Experimental Therapeutics Clinical Trials Network (ETCTN). She performs duties as a Program Official, a Level II FAC-Contract Officer's Representative (COR), and Program Analyst. As a Program Official, her portfolio includes clinical research projects focused on bioethics.

Kim graduated from the University of Kansas in 1981 with a Bachelor of Science degree in Microbiology. After graduation, she worked as a Production Technician for Meloy Laboratories, a subsidiary of Revlon. In September 1982, Kim began her career as a federal government employee working for the Department of Defense. As a Biological Laboratory Technician in a Department of Medicine research laboratory at the Uniformed Services University of the Health Sciences (USUHS), she rapidly advanced to become the laboratory manager and co-author on a number of scientific publications. After 18 years of service at USUHS, she accepted a position as a Biologist in CTEP. Between 2009 and 2010 Kim received her dual Master degrees from the University of Maryland University College in Business Administration and Biotechnology specializing in Biodefense and Biosecurity.